194 related articles for article (PubMed ID: 32522981)
1. mTADA is a framework for identifying risk genes from de novo mutations in multiple traits.
Nguyen TH; Dobbyn A; Brown RC; Riley BP; Buxbaum JD; Pinto D; Purcell SM; Sullivan PF; He X; Stahl EA
Nat Commun; 2020 Jun; 11(1):2929. PubMed ID: 32522981
[TBL] [Abstract][Full Text] [Related]
2. Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.
Li J; Cai T; Jiang Y; Chen H; He X; Chen C; Li X; Shao Q; Ran X; Li Z; Xia K; Liu C; Sun ZS; Wu J
Mol Psychiatry; 2016 Feb; 21(2):290-7. PubMed ID: 25849321
[TBL] [Abstract][Full Text] [Related]
3. Identification of De Novo DNMT3A Mutations That Cause West Syndrome by Using Whole-Exome Sequencing.
Liu Z; Li Z; Zhi X; Du Y; Lin Z; Wu J
Mol Neurobiol; 2018 Mar; 55(3):2483-2493. PubMed ID: 28386848
[TBL] [Abstract][Full Text] [Related]
4. M-DATA: A statistical approach to jointly analyzing de novo mutations for multiple traits.
Xie Y; Li M; Dong W; Jiang W; Zhao H
PLoS Genet; 2021 Nov; 17(11):e1009849. PubMed ID: 34735430
[TBL] [Abstract][Full Text] [Related]
5. Quantifying concordant genetic effects of de novo mutations on multiple disorders.
Guo H; Hou L; Shi Y; Jin SC; Zeng X; Li B; Lifton RP; Brueckner M; Zhao H; Lu Q
Elife; 2022 Jun; 11():. PubMed ID: 35666111
[TBL] [Abstract][Full Text] [Related]
6. Integrative modeling of transmitted and
Li M; Zeng X; Jin C; Jin SC; Dong W; Brueckner M; Lifton R; Lu Q; Zhao H
Quant Biol; 2021 Jun; 9(2):216-227. PubMed ID: 35414959
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations.
Howrigan DP; Rose SA; Samocha KE; Fromer M; Cerrato F; Chen WJ; Churchhouse C; Chambert K; Chandler SD; Daly MJ; Dumont A; Genovese G; Hwu HG; Laird N; Kosmicki JA; Moran JL; Roe C; Singh T; Wang SH; Faraone SV; Glatt SJ; McCarroll SA; Tsuang M; Neale BM
Nat Neurosci; 2020 Feb; 23(2):185-193. PubMed ID: 31932770
[TBL] [Abstract][Full Text] [Related]
8. Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders.
Li K; Fang Z; Zhao G; Li B; Chen C; Xia L; Wang L; Luo T; Wang X; Wang Z; Zhang Y; Jiang Y; Pan Q; Hu Z; Guo H; Tang B; Liu C; Sun Z; Xia K; Li J
J Autism Dev Disord; 2022 Mar; 52(3):1299-1313. PubMed ID: 33970367
[TBL] [Abstract][Full Text] [Related]
9. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability.
McCarthy SE; Gillis J; Kramer M; Lihm J; Yoon S; Berstein Y; Mistry M; Pavlidis P; Solomon R; Ghiban E; Antoniou E; Kelleher E; O'Brien C; Donohoe G; Gill M; Morris DW; McCombie WR; Corvin A
Mol Psychiatry; 2014 Jun; 19(6):652-8. PubMed ID: 24776741
[TBL] [Abstract][Full Text] [Related]
10. A Statistical Framework for Mapping Risk Genes from De Novo Mutations in Whole-Genome-Sequencing Studies.
Liu Y; Liang Y; Cicek AE; Li Z; Li J; Muhle RA; Krenzer M; Mei Y; Wang Y; Knoblauch N; Morrison J; Zhao S; Jiang Y; Geller E; Ionita-Laza I; Wu J; Xia K; Noonan JP; Sun ZS; He X
Am J Hum Genet; 2018 Jun; 102(6):1031-1047. PubMed ID: 29754769
[TBL] [Abstract][Full Text] [Related]
11. A de novo pathogenic CSNK1E mutation identified by exome sequencing in family trios with epileptic encephalopathy.
Chen X; Jin J; Wang Q; Xue H; Zhang N; Du Y; Zhang T; Zhang B; Wu J; Liu Z
Hum Mutat; 2019 Mar; 40(3):281-287. PubMed ID: 30488659
[TBL] [Abstract][Full Text] [Related]
12.
Luo T; Li K; Ling Z; Zhao G; Li B; Wang Z; Wang X; Han Y; Xia L; Zhang Y; Zhou Q; Fang Z; Wang Y; Chen Q; Zhou X; Pan H; Zhao Y; Wang Y; Dong L; Huang Y; Hu Z; Pan Q; Xia K; Li J
Comput Struct Biotechnol J; 2021; 19():1414-1422. PubMed ID: 33777337
[TBL] [Abstract][Full Text] [Related]
13. De novo mutations in epileptic encephalopathies.
; ; Allen AS; Berkovic SF; Cossette P; Delanty N; Dlugos D; Eichler EE; Epstein MP; Glauser T; Goldstein DB; Han Y; Heinzen EL; Hitomi Y; Howell KB; Johnson MR; Kuzniecky R; Lowenstein DH; Lu YF; Madou MR; Marson AG; Mefford HC; Esmaeeli Nieh S; O'Brien TJ; Ottman R; Petrovski S; Poduri A; Ruzzo EK; Scheffer IE; Sherr EH; Yuskaitis CJ; Abou-Khalil B; Alldredge BK; Bautista JF; Berkovic SF; Boro A; Cascino GD; Consalvo D; Crumrine P; Devinsky O; Dlugos D; Epstein MP; Fiol M; Fountain NB; French J; Friedman D; Geller EB; Glauser T; Glynn S; Haut SR; Hayward J; Helmers SL; Joshi S; Kanner A; Kirsch HE; Knowlton RC; Kossoff EH; Kuperman R; Kuzniecky R; Lowenstein DH; McGuire SM; Motika PV; Novotny EJ; Ottman R; Paolicchi JM; Parent JM; Park K; Poduri A; Scheffer IE; Shellhaas RA; Sherr EH; Shih JJ; Singh R; Sirven J; Smith MC; Sullivan J; Lin Thio L; Venkat A; Vining EP; Von Allmen GK; Weisenberg JL; Widdess-Walsh P; Winawer MR
Nature; 2013 Sep; 501(7466):217-21. PubMed ID: 23934111
[TBL] [Abstract][Full Text] [Related]
14. Analysis workflow to assess
Diab NS; King S; Dong W; Allington G; Sheth A; Peters ST; Kahle KT; Jin SC
STAR Protoc; 2021 Mar; 2(1):100383. PubMed ID: 33748785
[TBL] [Abstract][Full Text] [Related]
15. Implications of de novo mutations in guiding drug discovery: A study of four neuropsychiatric disorders.
So HC; Wong YH
J Psychiatr Res; 2019 Mar; 110():83-92. PubMed ID: 30597425
[TBL] [Abstract][Full Text] [Related]
16. De-novo mutations in patients with chronic ultra-refractory epilepsy with onset after age five years.
McCormack M; McGinty RN; Zhu X; Slattery L; Heinzen EL; ; Costello DJ; Delanty N; Cavalleri GL
Eur J Med Genet; 2020 Jan; 63(1):103625. PubMed ID: 30711678
[TBL] [Abstract][Full Text] [Related]
17. High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies.
Hamdan FF; Myers CT; Cossette P; Lemay P; Spiegelman D; Laporte AD; Nassif C; Diallo O; Monlong J; Cadieux-Dion M; Dobrzeniecka S; Meloche C; Retterer K; Cho MT; Rosenfeld JA; Bi W; Massicotte C; Miguet M; Brunga L; Regan BM; Mo K; Tam C; Schneider A; Hollingsworth G; ; FitzPatrick DR; Donaldson A; Canham N; Blair E; Kerr B; Fry AE; Thomas RH; Shelagh J; Hurst JA; Brittain H; Blyth M; Lebel RR; Gerkes EH; Davis-Keppen L; Stein Q; Chung WK; Dorison SJ; Benke PJ; Fassi E; Corsten-Janssen N; Kamsteeg EJ; Mau-Them FT; Bruel AL; Verloes A; Õunap K; Wojcik MH; Albert DVF; Venkateswaran S; Ware T; Jones D; Liu YC; Mohammad SS; Bizargity P; Bacino CA; Leuzzi V; Martinelli S; Dallapiccola B; Tartaglia M; Blumkin L; Wierenga KJ; Purcarin G; O'Byrne JJ; Stockler S; Lehman A; Keren B; Nougues MC; Mignot C; Auvin S; Nava C; Hiatt SM; Bebin M; Shao Y; Scaglia F; Lalani SR; Frye RE; Jarjour IT; Jacques S; Boucher RM; Riou E; Srour M; Carmant L; Lortie A; Major P; Diadori P; Dubeau F; D'Anjou G; Bourque G; Berkovic SF; Sadleir LG; Campeau PM; Kibar Z; Lafrenière RG; Girard SL; Mercimek-Mahmutoglu S; Boelman C; Rouleau GA; Scheffer IE; Mefford HC; Andrade DM; Rossignol E; Minassian BA; Michaud JL
Am J Hum Genet; 2017 Nov; 101(5):664-685. PubMed ID: 29100083
[TBL] [Abstract][Full Text] [Related]
18. The pleiotropy associated with de novo variants in CHD4, CNOT3, and SETD5 extends to moyamoya angiopathy.
Pinard A; Guey S; Guo D; Cecchi AC; Kharas N; Wallace S; Regalado ES; Hostetler EM; Sharrief AZ; Bergametti F; Kossorotoff M; Hervé D; Kraemer M; Bamshad MJ; Nickerson DA; Smith ER; Tournier-Lasserve E; Milewicz DM
Genet Med; 2020 Feb; 22(2):427-431. PubMed ID: 31474762
[TBL] [Abstract][Full Text] [Related]
19. Whole-exome sequencing identifies a novel de novo mutation in DYNC1H1 in epileptic encephalopathies.
Lin Z; Liu Z; Li X; Li F; Hu Y; Chen B; Wang Z; Liu Y
Sci Rep; 2017 Mar; 7(1):258. PubMed ID: 28325891
[TBL] [Abstract][Full Text] [Related]
20. Three intellectual disability-associated de novo mutations in MECP2 identified by trio-WES analysis.
Gu Y; Xiang B; Zhu L; Ma X; Chen X; Cai T
BMC Med Genet; 2020 May; 21(1):99. PubMed ID: 32393352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
